Publication
The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
Journal Paper/Review - Dec 1, 2006
Schmid Christoph, Brändle Michael
Units
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin, Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen
PubMed
Doi
Citation
Schmid C, Brändle M. The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clinical endocrinology 2006; 65:827-8.
Type
Journal Paper/Review (English)
Journal
Clinical endocrinology 2006; 65
Publication Date
Dec 1, 2006
Issn Print
0300-0664
Pages
827-8